A5078589236- Helicobacter pylori-related gastroenterology studies
- Gut microbiota and health
- Biosimilars and Bioanalytical Methods
- Veterinary medicine and infectious diseases
- Diet and metabolism studies
- Platelet Disorders and Treatments
- Gastric Cancer Management and Outcomes
- Nutritional Studies and Diet
- Gastrointestinal motility and disorders
- IgG4-Related and Inflammatory Diseases
- Advanced Biosensing Techniques and Applications
- Neuroendocrine Tumor Research Advances
- Microscopic Colitis
- Gastroesophageal reflux and treatments
- Biosensors and Analytical Detection
Loma Linda University
2023
Loma Linda University Medical Center
2023
Cooper Medical School of Rowan University
2018-2020
Ragon Institute of MGH, MIT and Harvard
2017
Exclusive breastfeeding promotes gut microbial compositions associated with lower rates of metabolic and autoimmune diseases. Its cessation is implicated in increased microbiome-metabolome discordance, suggesting a vulnerability to dietary changes. Formula supplementation common within our low-income, ethnic-minority community. We studied exclusively breastfed (EBF) neonates' early coupling efforts build foundational knowledge needed target this inequality.Maternal surveys stool samples from...
Abstract Background Regional variation in Helicobacter pylori resistance patterns is a significant contributing factor for the ineffectiveness of traditional treatments. To improve treatment outcomes, we sought to create an individualized, susceptibility‐driven therapeutic approach among our patient population, which one poorest nation. It medically underserved, minority‐predominant and has high incidence H infection. Methods We compiled various factors involved antibiotic from literature....
Introduction: Infecting almost 50% of the world's population, Helicobacter pylori plays a causal role in pathogenesis chronic gastritis, peptic ulcer disease and gastric cancers. Management such prevalent gastrointestinal disorders has become increasingly challenging due to global increase H. resistance antibiotics. An individualized, susceptibility—driven therapeutic approach may help control rising rates improve patient outcomes. In 2017 ACG conference, we presented preliminary results our...